Cargando…

Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes

The potential mechanism of myelodysplastic syndromes (MDS) progressing to acute myeloid leukemia (AML) remains poorly elucidated. It has been proved that epigenetic alterations play crucial roles in the pathogenesis of cancer progression including MDS. However, fewer studies explored the whole-genom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jing-dong, Zhang, Ting-juan, Xu, Zi-jun, Deng, Zhao-qun, Gu, Yu, Ma, Ji-chun, Wen, Xiang-mei, Leng, Jia-yan, Lin, Jiang, Chen, Su-ning, Qian, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679421/ https://www.ncbi.nlm.nih.gov/pubmed/33219204 http://dx.doi.org/10.1038/s41419-020-03213-2

Ejemplares similares

Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms
por: Zhang, Ting‐juan, et al.
Publicado: (2020)

Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes
por: Zhou, Jing-dong, et al.
Publicado: (2022)

GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome
por: Zhou, Jing‐Dong, et al.
Publicado: (2016)

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes
por: Xu, Feng, et al.
Publicado: (2015)

Identifying New Epigenetic Drivers of Liver Fibrosis
por: Argemi, Josepmaria, et al.
Publicado: (2018)

Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes
por: Cedena, M. Teresa, et al.
Publicado: (2017)

SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2019)

Functional genomics analysis identifies T and NK cell activation as a driver of epigenetic clock progression
por: Jonkman, Thomas H., et al.
Publicado: (2022)

Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response
por: Siamoglou, Stavroula, et al.
Publicado: (2023)

Genome-wide methylation analysis identified sexually dimorphic methylated regions in hybrid tilapia
por: Wan, Zi Yi, et al.
Publicado: (2016)

Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes
por: Cedena, M. Teresa, et al.
Publicado: (2018)

Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2021)

Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis
por: Chatterjee, Aniruddha, et al.
Publicado: (2016)

An information-theory analysis of DNA methylation identifies converging genetic and epigenetic drivers of paediatric acute lymphoblastic leukaemia
por: Koldobskiy, Michael A., et al.
Publicado: (2021)

Genome-Wide Methylation Analysis Identifies Specific Epigenetic Marks In Severely Obese Children
por: Fradin, Delphine, et al.
Publicado: (2017)

Genome-wide screens identify specific drivers of mutant hTERT promoters
por: Shanmugam, Raghuvaran, et al.
Publicado: (2022)

Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome
por: Baliakas, Panagiotis, et al.
Publicado: (2021)

Molecular Drivers of Myelodysplastic Neoplasms (MDS)—Classification and Prognostic Relevance
por: Hoff, Fieke W., et al.
Publicado: (2023)

DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis
por: Zhou, Jing-dong, et al.
Publicado: (2022)

Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis
por: Lian, Xin-yue, et al.
Publicado: (2016)

Genome-wide DNA methylation profiling identifies epigenetic signatures of gastric cardiac intestinal metaplasia
por: Lin, Runhua, et al.
Publicado: (2020)

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)

Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
por: Xie, Xiaoqing, et al.
Publicado: (2021)

Genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer
por: Zhang, Chuanjie, et al.
Publicado: (2019)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Azacitidine regulates DNA methylation of GADD45γ in myelodysplastic syndromes
por: Yang, Yanli, et al.
Publicado: (2020)

LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome
por: Kaastrup, Katja, et al.
Publicado: (2023)

Detection of SRSF2-P95 Mutation by High-Resolution Melting Curve Analysis and Its Effect on Prognosis in Myelodysplastic Syndrome
por: Lin, Jiang, et al.
Publicado: (2014)

Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer
por: Song, Peng, et al.
Publicado: (2022)

Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine
por: McCormack, Steven E, et al.
Publicado: (2010)

DNA methylation variation along the cancer epigenome and the identification of novel epigenetic driver events
por: Heery, Richard, et al.
Publicado: (2021)

Epigenetic Drivers in Pediatric Medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2017)

An Overview of Epigenetic Methylation in Pancreatic Cancer Progression
por: Zhao, Yuhao, et al.
Publicado: (2022)

The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes
por: Berastegui, Nerea, et al.
Publicado: (2022)

Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitus
por: Hwang, Joo-Yeon, et al.
Publicado: (2018)

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome
por: Xu, Feng, et al.
Publicado: (2016)

Driver Gene Alterations in Malignant Progression of Gastric Cancer
por: Dong, Yuanqiang, et al.
Publicado: (2022)

Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome
por: Jung, Hyun Ae, et al.
Publicado: (2021)

Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights
por: Shahrabi, Saeid, et al.
Publicado: (2016)

Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies
por: Zhou, Jing‐dong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s77j73nglln0sj93tfkhar3i1o